Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Lancet Public Health. 2023 Apr;8(4):e256-e265. doi: 10.1016/S2468-2667(23)00027-0. Epub 2023 Mar 16.
Football (soccer) players might be at increased risk of neurodegenerative disease, which has led to questions regarding the safety of the sport and recent measures introduced by football associations to reduce heading of the ball. We aimed to assess the risk of neurodegenerative disease among male football players in the Swedish top division Allsvenskan, compared with matched controls.
In this cohort study, we identified all male football players (amateurs and professionals) who had played at least one game in Allsvenskan from Aug 1, 1924 to Dec 31, 2019 and excluded players whose personal identity number could not be retrieved or be identified in the Total Population Register, and those who were not born in Sweden and who had immigrated to the country after age 15 years. Football players were matched with up to ten controls from the general population according to sex, age, and region of residence. We used nationwide registers to compare the risk of neurodegenerative disease (diagnoses recorded in death certificates, during hospital admissions and outpatient visits, or use of prescription drugs for dementia) among football players versus controls. We also assessed each type of neurodegenerative disease (Alzheimer's disease and other dementias, motor neuron disease, and Parkinson's disease) separately, and compared the risk of neurodegenerative disease among outfield players versus goalkeepers.
Of 7386 football players who had played at least one game in the top Swedish division between Aug 1, 1924, and Dec 31, 2019, 182 players were excluded for an unretrievable personal identity number, and 417 were excluded due to their number not being identified in the Total Population Register. After a further exclusion of 780 players and 11 627 controls who were born outside of Sweden and who had immigrated to the country after age 15 years, 6007 football players (510 goalkeepers) were included in the study population along with 56 168 matched controls. During follow-up to Dec 31, 2020, 537 (8·9%) of 6007 football players and 3485 (6·2%) of 56 168 controls were diagnosed with neurodegenerative disease. The risk of neurodegenerative disease was higher among football players than controls (hazard ratio [HR] 1·46 [95% CI 1·33-1·60]). Alzheimer's disease and other dementias were more common among football players than controls (HR 1·62 [95% CI 1·47-1·78]), significant group differences were not observed for motor neuron disease (HR 1·27 [0·73-2·22]), and Parkinson's disease was less common among football players (HR 0·68 [0·52-0·89]). The risk of neurodegenerative disease was higher for outfield players than controls (HR 1·50 [95% CI 1·36-1·65]) but not for goalkeepers versus controls (HR 1·07 [0·78-1·47]), and outfield players had a higher risk of neurodegenerative disease than did goalkeepers (HR 1·43 [1·03-1·99]). All-cause mortality was slightly lower among football players than controls (HR 0·95 [95% CI 0·91-0·99]).
In this cohort study, male football players who had played in the Swedish top division had a significantly increased risk of neurodegenerative disease compared with population controls. The risk increase was observed for Alzheimer's disease and other dementias but not for other types of neurodegenerative disease, and among outfield players, but not among goalkeepers. Our study expands on the data that can be used to assess and manage risks in the sport.
Karolinska Institutet, The Swedish Research Council for Sport Science, Folksam Research Foundation, Hedberg Foundation, Neurofonden, and Åhlen Foundation.
足球(英式足球)运动员可能面临更高的神经退行性疾病风险,这引发了关于这项运动安全性的问题,以及足球协会最近采取的减少头球的措施。我们旨在评估瑞典顶级联赛 Allsvenskan 中男性足球运动员患神经退行性疾病的风险,并与匹配的对照组进行比较。
在这项队列研究中,我们确定了所有至少在 1924 年 8 月 1 日至 2019 年 12 月 31 日期间在 Allsvenskan 中踢过一场比赛的男性足球运动员(业余和职业球员),并排除了个人身份号码无法检索或在总人口登记册中无法识别的球员,以及那些不是在瑞典出生且在 15 岁以后移民到该国的球员。足球运动员根据性别、年龄和居住地区与多达 10 名对照组进行匹配。我们使用全国性登记册来比较足球运动员与对照组之间神经退行性疾病(死亡证明、住院和门诊就诊期间的诊断记录,或使用治疗痴呆症的处方药)的风险。我们还分别评估了每种类型的神经退行性疾病(阿尔茨海默病和其他痴呆症、运动神经元疾病和帕金森病),并比较了外场球员和守门员之间神经退行性疾病的风险。
在 1924 年 8 月 1 日至 2019 年 12 月 31 日期间至少在瑞典顶级联赛中踢过一场比赛的 7386 名足球运动员中,有 182 名因无法检索个人身份号码而被排除,有 417 名因在总人口登记册中未被识别而被排除。在进一步排除了 780 名球员和 11627 名出生在瑞典以外且在 15 岁以后移民到该国的对照组之后,共有 6007 名足球运动员(510 名守门员)和 56168 名匹配的对照组被纳入研究人群。截至 2020 年 12 月 31 日的随访期间,6007 名足球运动员中有 537 名(8.9%)和 56168 名对照组中有 3485 名(6.2%)被诊断为神经退行性疾病。与对照组相比,足球运动员患神经退行性疾病的风险更高(风险比[HR] 1.46 [95% CI 1.33-1.60])。与对照组相比,足球运动员患阿尔茨海默病和其他痴呆症的风险更高(HR 1.62 [95% CI 1.47-1.78]),但运动神经元疾病的组间差异不显著(HR 1.27 [0.73-2.22]),帕金森病的风险较低(HR 0.68 [0.52-0.89])。与对照组相比,外场球员患神经退行性疾病的风险更高(HR 1.50 [95% CI 1.36-1.65]),但守门员与对照组之间的风险无显著差异(HR 1.07 [0.78-1.47]),外场球员的神经退行性疾病风险高于守门员(HR 1.43 [1.03-1.99])。与对照组相比,所有原因导致的死亡率在足球运动员中略低(HR 0.95 [95% CI 0.91-0.99])。
在这项队列研究中,曾在瑞典顶级联赛中踢球的男性足球运动员与对照组人群相比,患神经退行性疾病的风险显著增加。这种风险增加见于阿尔茨海默病和其他痴呆症,但其他类型的神经退行性疾病除外,而且在外场球员中,而不是守门员中。我们的研究扩展了可用于评估和管理该运动风险的数据。
卡罗林斯卡学院、瑞典研究理事会运动科学、Folksam 研究基金会、Hedberg 基金会、神经基金会和 Åhlen 基金会。